{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:44:54Z","timestamp":1791315894932,"version":"4.3.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00774-015-0667-1","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T12:21:48Z","timestamp":1433247708000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["IFITM5 mutations and osteogenesis imperfecta"],"prefix":"10.1007","volume":"34","author":[{"given":"Nobutaka","family":"Hanagata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"667_CR1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","volume":"139","author":"AL Brass","year":"2009","unstructured":"Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243\u20131254","journal-title":"Cell"},{"key":"667_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2013","unstructured":"Everitt AR, Clare S, Pertel T, John SP, Wash RS et al (2013) IFITM3 restricts the mobidity and mortality associated with influenza. Nature 484:519\u2013523","journal-title":"Nature"},{"key":"667_CR3","doi-asserted-by":"crossref","first-page":"e1002909","DOI":"10.1371\/journal.ppat.1002909","volume":"8","author":"CC Bailey","year":"2012","unstructured":"Bailey CC, Huang IC, Kam C, Farzan M (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 8:e1002909","journal-title":"PLoS Pathog"},{"key":"667_CR4","doi-asserted-by":"crossref","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","volume":"7","author":"IC Huang","year":"2011","unstructured":"Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus and influenza A virus. PLoS Pathog 7:e1001258","journal-title":"PLoS Pathog"},{"key":"667_CR5","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1093\/nar\/gkf542","volume":"30","author":"P Moffatt","year":"2002","unstructured":"Moffatt P, Salois P, Gaumond MH, St-Amant N, Godin E, Lanctot C (2002) Engineered viruses to select genes encoding secreted and membrane-bound proteins in mammalian cells. Nucleic Acids Res 30:4285\u20134294","journal-title":"Nucleic Acids Res"},{"key":"667_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jbm.a.31240","volume":"83A","author":"N Hanagata","year":"2007","unstructured":"Hanagata N, Takemura T, Monkawa A, Ikoma T, Tanaka J (2007) Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J Biomed Mater Res Part A 83A:362\u2013371","journal-title":"J Biomed Mater Res Part A"},{"key":"667_CR7","doi-asserted-by":"crossref","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","volume":"9","author":"K Li","year":"2013","unstructured":"Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9:e1003124","journal-title":"PLoS Pathog"},{"key":"667_CR8","doi-asserted-by":"crossref","first-page":"e1002337","DOI":"10.1371\/journal.ppat.1002337","volume":"7","author":"EM Feeley","year":"2011","unstructured":"Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337","journal-title":"PLoS Pathog"},{"key":"667_CR9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1359\/jbmr.080412","volume":"23","author":"P Moffatt","year":"2008","unstructured":"Moffatt P, Gaumond MH, Salois P, Sellin K, Beestte MC, Godin E, de Oliveira PT, Atkins GJ, Nanci A, Thomas G (2008) Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23:1497\u20131508","journal-title":"J Bone Miner Res"},{"key":"667_CR10","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jbmr.2243","volume":"29","author":"A Patoine","year":"2014","unstructured":"Patoine A, Gaumond MH, Jaiswal PK, Fassier F, Rauch F, Moffatt P (2014) Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfect mutations on its cellular destination. J Bone Miner Res 29:2004\u20132016","journal-title":"J Bone Miner Res"},{"key":"667_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00774-010-0221-0","volume":"29","author":"N Hanagata","year":"2011","unstructured":"Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29:279\u2013290","journal-title":"J Bone Miner Metab"},{"key":"667_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","volume":"91","author":"TJ Cho","year":"2012","unstructured":"Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D, Lee G, Kim HN, Lee HR, Eom HH, Lee ZH, Kim OH, Park WY, Park SS, Ikegawa S, Yoo WJ, Choi IH, Kim JW (2012) A single recurrent mutation in the 5\u2032-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 91:343\u2013348","journal-title":"Am J Hum Genet"},{"key":"667_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","volume":"91","author":"O Semler","year":"2012","unstructured":"Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, Iden S, Wirth B, Eysel P, Koerber F, Schoenau E, Bohlander SK, Wollnik B, Netzer C (2012) A mutation in the 5\u2032-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 91:349\u2013357","journal-title":"Am J Hum Genet"},{"key":"667_CR14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/jbmr.2156","volume":"29","author":"H Koyer-Kuhn","year":"2014","unstructured":"Koyer-Kuhn H, Semler O, Garbes L, Zimmermann K, Becker J, Wollnik B, Schoenau E, Netzer C (2014) A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfect with prenatal onset. J Bone Miner Res 29:1387\u20131391","journal-title":"J Bone Miner Res"},{"key":"667_CR15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ajmg.a.36409","volume":"164A","author":"E Guillen-Navarro","year":"2014","unstructured":"Guillen-Navarro E, Ballesta-Martinez MJ, Valencia M, Bueno AM, Martinez-Glez V, Lopez-Gonzalez V, Burnyte B, Utkus A, Lapunzia P, Ruiz-Perez VL (2014) Two mutations in IFITM5 causing distinct form of osteogenesis imperfect. Am J Med Genet A 164A:1136\u20131142","journal-title":"Am J Med Genet A"},{"key":"667_CR16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/jbmr.2173","volume":"29","author":"CR Farber","year":"2014","unstructured":"Farber CR, Reich A, Barnes AM, Becerra P, Rauch F, Cabral WA, Bae A, Quinlan A, Glorieux FH, Clemens TL, Marini JC (2014) A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res 29:1402\u20131411","journal-title":"J Bone Miner Res"},{"key":"667_CR17","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini JC, Blissett AR (2013) New genes in bone development: what\u2019s new in osteogenesis imperfect. J Clin Endocrinol Metab 98:3095\u20133103","journal-title":"J Clin Endocrinol Metab"},{"key":"667_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/nar\/25.1.181","volume":"25","author":"R Dalgleish","year":"1997","unstructured":"Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Res 25:181\u2013187","journal-title":"Nucleic Acids Res"},{"key":"667_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/nar\/26.1.253","volume":"26","author":"R Dalgleish","year":"1998","unstructured":"Dalgleish R (1998) The human type I collagen mutation database 1998. Nucleic Acids Res 26:253\u2013255","journal-title":"Nucleic Acids Res"},{"key":"667_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD et al (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209\u2013221","journal-title":"Hum Mutat"},{"key":"667_CR21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJM197705262962104","volume":"296","author":"B Sykes","year":"1977","unstructured":"Sykes B, Francis MJ, Smith R (1977) Altered relation of two collagen types in osteogenesis inmperfecta. N Engl J Med 296:1200\u20131203","journal-title":"N Engl J Med"},{"key":"667_CR22","first-page":"501","volume":"36","author":"RL Trelstad","year":"1977","unstructured":"Trelstad RL, Rubin D, Gross J (1977) Osteogenesis imperfecta congenital: evidence for a generalized molecular disorder of collagen. Lab Invest 36:501\u2013508","journal-title":"Lab Invest"},{"key":"667_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/304078a0","volume":"304","author":"ML Chu","year":"1983","unstructured":"Chu ML, Williams CJ, Pepe G, Hirsch JL, Prockop DJ, Ramirez F (1983) Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature 304:78\u201380","journal-title":"Nature"},{"key":"667_CR24","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1016\/S0021-9258(18)90631-9","volume":"259","author":"B Steinmann","year":"1984","unstructured":"Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann R, Byers PH (1984) Cysteine in the triple-helical domain of one allelic product of the alpha 1 (I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem 259:11129\u201311138","journal-title":"J Biol Chem"},{"key":"667_CR25","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1073\/pnas.83.16.6045","volume":"83","author":"DH Cohn","year":"1986","unstructured":"Cohn DH, Byers PH, Steinmann B, Gelinas RE (1986) Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro plpha 1(I) collagen allele. Proc Natl Acad Sci USA 83:6045\u20136047","journal-title":"Proc Natl Acad Sci USA"},{"key":"667_CR26","first-page":"293","volume":"46","author":"B Sykes","year":"1990","unstructured":"Sykes B, Ogilvie D, Wordsworth P, Wallis G, Mathew C, Beighton P, Nicholls A, Pope FM, Thompson E, Tsipouras P, Schwartz R, Jensson O, Arnason A, B\u00f8rresen A-L, Heiberg A, Frey D, Steinman B (1990) Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet 46:293\u2013307","journal-title":"Am J Hum Genet"},{"key":"667_CR27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291\u2013304","journal-title":"Cell"},{"key":"667_CR28","first-page":"543","volume":"14","author":"WA Cabral","year":"2012","unstructured":"Cabral WA, Barnes AM, Adeyemo A, Cushing K, Chitayat D, Porter FD, Panny SR, Gulamali-Majid F, Tishkoff SA, Rebbeck TR, Gueye SM, Bailey-Wilson JE, Brody LC, Rotimi CN, Marini JC (2012) A founder mutation in LEPRE1 carried by 1.5\u00a0% of West Africans and 0.4\u00a0% of African Americans causes lethal recessive osteogenesis imperfecta. Genet Med Off J Am Coll Med Genet 14:543\u2013551","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"667_CR29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajhg.2009.09.001","volume":"85","author":"FS Dijk van","year":"2009","unstructured":"van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MH, Elting MW, Verbeke JI, Wijnaendts LC, Shaw NJ, Hogler W, McKeown C, Sistermans EA, Dalton A, Meijers-Heijboer H, Pals G (2009) PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85:521\u2013527","journal-title":"Am J Hum Genet"},{"key":"667_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","volume":"86","author":"HE Christiansen","year":"2010","unstructured":"Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389\u2013398","journal-title":"Am J Hum Genet"},{"key":"667_CR31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","volume":"86","author":"Y Alanay","year":"2010","unstructured":"Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K et al (2010) Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfect. Am J Hum Genet 86:551\u2013559","journal-title":"Am J Hum Genet"},{"key":"667_CR32","doi-asserted-by":"crossref","first-page":"e1000579","DOI":"10.1371\/journal.pgen.1000579","volume":"5","author":"C Dr\u00f6gem\u00fcller","year":"2009","unstructured":"Dr\u00f6gem\u00fcller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, Fehr M, Baumann U, Lindblad-Toh K, Leeb T (2009) A missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfecta. PLoS Genet 5:e1000579","journal-title":"PLoS Genet"},{"key":"667_CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","volume":"86","author":"HE Christiansen","year":"2010","unstructured":"Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Balwi MA, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389\u2013398","journal-title":"Am J Hum Genet"},{"key":"667_CR34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.21647","volume":"33","author":"V Mart\u00ednez-Glez","year":"2012","unstructured":"Mart\u00ednez-Glez V, Valencia M, Caparr\u00f3s-Mart\u00edn JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL (2012) Identification of a mutation causing deficient BMP1\/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33:343\u2013350","journal-title":"Hum Mutat"},{"issue":"12","key":"667_CR35","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26(12):2798\u20132803","journal-title":"J Bone Miner Res"},{"key":"667_CR36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362\u2013371","journal-title":"Am J Hum Genet"},{"key":"667_CR37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","volume":"87","author":"P Lapunzina","year":"2010","unstructured":"Lapunzina P, Aglan M, Temtamy S, Caparr\u00f3s-Mart\u00edn JA, Valencia M, Let\u00f3n R, Mart\u00ednez-Glez V, Elhossini R, Amr K, Vilaboa N, Ruiz-Perez VL (2010) Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87:110\u2013114","journal-title":"Am J Hum Genet"},{"key":"667_CR38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jmedgenet-2012-101142","volume":"49","author":"R Shaheen","year":"2012","unstructured":"Shaheen R, Alazami AM, Alshammari MJ, Faqeih E, Alhashmi N, Mousa N, Alsinani A, Ansari S, Alzahrani F, Al-Owain M, Alzayed ZS, Alkuraya FS (2012) Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation. J Med Genet 49:630\u2013635","journal-title":"J Med Genet"},{"key":"667_CR39","first-page":"582","volume":"34","author":"M Volodarsky","year":"2013","unstructured":"Volodarsky M, Markus B, Cohen I, Staretz-Chacham O, Flusser H, Landau D, Shelef I, Langer Y, Birk OS (2013) A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta. Hum Mutat 34:582\u2013586","journal-title":"Hum Mutat"},{"key":"667_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","volume":"92","author":"K Keupp","year":"2013","unstructured":"Keupp K, Beleggia F, Kayserili H, Staretz-Chacham O, Flusser H, Landau D, Shelef I, Langer Y, Birk OS (2013) Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet 92:565\u2013574","journal-title":"Am J Hum Genet"},{"key":"667_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2013-101567","volume":"50","author":"S Fahiminiya","year":"2013","unstructured":"Fahiminiya S, Majewski J, Mort J, Moffatt P, Glorieux FH, Rauch F (2013) Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet 50:345\u2013348","journal-title":"J Med Genet"},{"key":"667_CR42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2013.02.009","volume":"92","author":"SM Pyott","year":"2013","unstructured":"Pyott SM, Tran TT, Leistritz DF, Pepin MG, Mendelsohn NJ, Temme RT, Fernandez BA, Elsayed SM, Elsobky E, Verma I, Nair S, Turner EH, Smith JD, Jarvik GP, Byers PH (2013) WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am J Hum Genet 92:590\u2013597","journal-title":"Am J Hum Genet"},{"key":"667_CR43","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ (2000) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650\u20131658","journal-title":"J Bone Miner Res"},{"key":"667_CR44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377\u20131385","journal-title":"Lancet"},{"key":"667_CR45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","volume":"50","author":"F Rauch","year":"2013","unstructured":"Rauch F, Moffatt P, Cheung M, Roughley P, Lalic L, Lund AM, Ramirez N, Fahiminiya S, Majewski J, Glorieux FH (2013) Osteogenesis imperfecta type V: Marker pheneotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients. J Med Genet 50:21\u201324","journal-title":"J Med Genet"},{"key":"667_CR46","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"JR Shapiro","year":"2013","unstructured":"Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC, Baldridge DM, Bainbridge MN, Cohn DH, Blazo M, Roberts TT, Brennen FS, Wu Y, Gibbs RA, Melvin P, Campeau PM, Lee BH (2013) Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res 28:1523\u20131530","journal-title":"J Bone Miner Res"},{"key":"667_CR47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1359\/jbmr.070418","volume":"22","author":"MS Cheung","year":"2007","unstructured":"Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 22:1181\u20131186","journal-title":"J Bone Miner Res"},{"key":"667_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2005.07.020","volume":"38","author":"L Zeitlin","year":"2006","unstructured":"Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH (2006) The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V. Bone 38:13\u201320","journal-title":"Bone"},{"key":"667_CR49","first-page":"37","volume":"1","author":"J Fitzgerald","year":"2013","unstructured":"Fitzgerald J, Holden P, Wright H, Wilmot B, Hata A, Steiner RD, Basel D (2013) Phenotypic variability in individuals with type V osteogenesis imperfecta with identical IFITM5 mutations. J Rare Disord 1:37\u201342","journal-title":"J Rare Disord"},{"key":"667_CR50","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/jbmr.258","volume":"26","author":"P Arundel","year":"2011","unstructured":"Arundel P, Offiah A, Bishop NJ (2011) Evolution of the radiographic appearance of the metaphyses over the first year of life in type V osteogenesis imperfecta: clues to pathogenesis. J Bone Miner Res 26:894\u2013898","journal-title":"J Bone Miner Res"},{"key":"667_CR51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","volume":"17","author":"FH Glorieux","year":"2002","unstructured":"Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30\u201338","journal-title":"J Bone Miner Res"},{"key":"667_CR52","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"PM Campeau","year":"2013","unstructured":"Campeau PM, Lee BH (2013) Phenotyic variability of osteogenesis imperfect type V caused by an IFITM5 mutation. J Bone Miner Res 28:1523\u20131530","journal-title":"J Bone Miner Res"},{"key":"667_CR53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCD.0b013e32836032f0","volume":"22","author":"M Balasubramanian","year":"2013","unstructured":"Balasubramanian M, Parker MJ, Dalton A, Giunta C, Lindert U, Peres LC, Wagner BE, Arundel P, Offiah A, Bishop NJ (2013) Genotype-phenotype study in type V osteogenesis imperfecta. Clin Dysmorphol 22:93\u2013101","journal-title":"Clin Dysmorphol"},{"key":"667_CR54","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/ajmg.a.36025","volume":"161A","author":"M Takagi","year":"2013","unstructured":"Takagi M, Sato S, Hara K, Tani C, Miyazaki O, Nishimura G, Hasegawa T (2013) A recurrent mutation in the 5\u2032-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Med Genet A 161A:1980\u20131982","journal-title":"Am J Med Genet A"},{"key":"667_CR55","doi-asserted-by":"crossref","first-page":"e72337","DOI":"10.1371\/journal.pone.0072337","volume":"8","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Li M, He JW, Fu WZ, Zhang CQ, Zhang ZL (2013) Phenotype and genotype analysis of Chinese patients with osteogenesis imperfect type V. PLoS One 8:e72337","journal-title":"PLoS One"},{"key":"667_CR56","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/jbmr.1983","volume":"28","author":"M Grover","year":"2013","unstructured":"Grover M, Campeau PM, Lietman CD, Lu JT, Gibbs RA, Schlesinger AE, Lee BH (2013) Osteogenesis imperfecta type without features of type V caused by a mutation in the IFITM5 gene. J Bone Miner Res 28:2333\u20132337","journal-title":"J Bone Miner Res"},{"key":"667_CR57","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/ajmg.a.36024","volume":"161A","author":"OH Kim","year":"2013","unstructured":"Kim OH, Jin DK, Kosaki K, Kim JW, Cho SY, Yoo WJ, Choi IH, Nishimura G, Ikegawa S, Cho TJ (2013) Osteogenesis imperfecta type V: Clinical and radiographic manifestations in mutation confirmed patients. Am J Med Genet A 161A:1972\u20131979","journal-title":"Am J Med Genet A"},{"key":"667_CR58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2474-15-107","volume":"15","author":"S Lazaus","year":"2014","unstructured":"Lazaus S, Mclnerney-Leo AM, McKenzie FA, Baynam G, Beoley S, Cavan BV, Munns CF, Pruijs JEH, Sillence D, Terhal PA, Pryce K, Brown M, Zankl A, Thomas G, Duncan EL (2014) The IFITM5 mutation c.-14C>T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskelet Disord 15:107","journal-title":"BMC Musculoskelet Disord"},{"key":"667_CR59","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/MCB.00272-08","volume":"28","author":"UC Lange","year":"2008","unstructured":"Lange UC, Adams DJ, Lee C, Barton S, Schneider R, Bradley A, Surani A (2008) Normal germ line establishment in mice carrying a deletion of the Ifitm\/Fragilis gene family cluster. Mol Cell Biol 28:4688\u20134696","journal-title":"Mol Cell Biol"},{"key":"667_CR60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jbmr.2363","volume":"30","author":"CD Lietman","year":"2015","unstructured":"Lietman CD, Marom R, Munivez E, Bertin TK, Jiang M-M, Chen Y, Dawson B, Weis MA, Eyre D, Lee B (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:498\u2013507","journal-title":"J Bone Miner Res"},{"key":"667_CR61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrc3484","volume":"13","author":"SP Becerra","year":"2013","unstructured":"Becerra SP, Notario V (2013) The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev Cancer 13:258\u2013271","journal-title":"Nat Rev Cancer"},{"key":"667_CR62","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/db10-0845","volume":"60","author":"ML Borg","year":"2011","unstructured":"Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60:1458\u20131466","journal-title":"Diabetes"},{"key":"667_CR63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245\u2013248","journal-title":"Science"},{"key":"667_CR64","first-page":"769","volume":"106","author":"S Filleur","year":"2009","unstructured":"Filleur S, Nelius T, de Riese W, Kennedy RC (2009) Characterization of PEDF: a multi-functional serpin family protein. J Cell Biol 106:769\u2013775","journal-title":"J Cell Biol"},{"key":"667_CR65","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.1892","volume":"28","author":"R Bogan","year":"2013","unstructured":"Bogan R, Riddle R, Li Z, Kumar S, Nandal A, Faugere M-C, Boskey A, Crawford SE, Clemens T (2013) A mouse model for human osteogenesis imperfecta type VI. J Bone Miner Res 28:1531\u20131536","journal-title":"J Bone Miner Res"},{"key":"667_CR66","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1096\/fj.13-232900","volume":"27","author":"AK Gattu","year":"2013","unstructured":"Gattu AK, Swenson ES, Iwakiri Y, Samuel VT, Troiano N, Berry R, Church CD, Rodeheffer MS, Carpenter TO, Chung C (2013) Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity, reduced bone mineral content. FASEB J 27:4384\u20134394","journal-title":"FASEB J"},{"key":"667_CR67","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/stem.1505","volume":"31","author":"F Li","year":"2013","unstructured":"Li F, Song N, Tombran-Tink J, Niyibizi C (2013) Pigment epithelium derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cell 31:2714\u20132723","journal-title":"Stem Cell"},{"key":"667_CR68","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2011.04.136","volume":"409","author":"N Hanagata","year":"2011","unstructured":"Hanagata N, Li X (2011) Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes. Biochem Biophys Res Commun 409:378\u2013384","journal-title":"Biochem Biophys Res Commun"},{"key":"667_CR69","doi-asserted-by":"crossref","first-page":"e75831","DOI":"10.1371\/journal.pone.0075831","volume":"8","author":"T Tsukamoto","year":"2013","unstructured":"Tsukamoto T, Li X, Morita H, Minowa T, Aizawa T, Hanagata N, Demura M (2013) Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells. PLoS One 8:e75831","journal-title":"PLoS One"},{"key":"667_CR70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jbmr.250","volume":"26","author":"BP Kelley","year":"2011","unstructured":"Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, Willaert A, Elcioglu N, Maldergem LV, Verellen-Dumoulin C, Gillerot Y, Napierala D, Krakow D, Beighton P, Superti-Furga A, Paepe AD, Lee B (2011) Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 26:666\u2013672","journal-title":"J Bone Miner Res"},{"key":"667_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/dds371","volume":"22","author":"U Schwarze","year":"2013","unstructured":"Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR et al (2013) Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Hum Mol Genet 22:1\u201317","journal-title":"Hum Mol Genet"},{"key":"667_CR72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2350-12-152","volume":"12","author":"O Steinlein","year":"2011","unstructured":"Steinlein O, Aichinger E, Trucks H, Sander T (2011) Mutations in FKBP10 can cause a severe form of isolated osteogenesis imperfecta. BMC Med Genet 12:152","journal-title":"BMC Med Genet"},{"key":"667_CR73","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1093\/hmg\/ddu197","volume":"23","author":"C Lietman","year":"2014","unstructured":"Lietman C, Rajagopal A, Homan EP, Munivez E, Jiang M-M, Bertin TK, Chen Y, Hicks J, Weis M, Eyre D, Lee B, Krakow D (2014) Connective tissue alterations in FKBP10 \u2212\/\u2212 mice. Hum Mol Genet 23:4822\u20134831","journal-title":"Hum Mol Genet"},{"key":"667_CR74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.biochem.73.011303.073954","volume":"73","author":"JE Smotry","year":"2004","unstructured":"Smotry JE, Linder ME (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73:559\u2013587","journal-title":"Annu Rev Biochem"},{"key":"667_CR75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2011.01.001","volume":"47","author":"IM Ahearn","year":"2011","unstructured":"Ahearn IM, Tsai FD, Court H, Zhou M, Jennings BC, Ahmed M, Fehrenbacher N, Linder ME, Phillip MR (2011) FKBP12 binds to acylated H-Ras and promotes depalmitoylation. Mol Cell 47:173\u2013185","journal-title":"Mol Cell"},{"key":"667_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1083\/jcb.200502063","volume":"170","author":"JS Goodwin","year":"2005","unstructured":"Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Phillips MR, Kenworthy AK (2005) Depalmitoylated Ras traffics to and from the Gorgi complex via a nonvesicular pathway. J Cell Biol 170:261\u2013272","journal-title":"J Cell Biol"},{"key":"667_CR77","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1126\/science.1105654","volume":"307","author":"O Rocks","year":"2005","unstructured":"Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M, Kuhlmann J, Waldmann H, Wittinghofer A, Bastiaens PI (2005) An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307:1746\u20131752","journal-title":"Science"},{"key":"667_CR78","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cell.2010.04.007","volume":"141","author":"O Rocks","year":"2010","unstructured":"Rocks O, Gerauer M, Vartak N, Koch S, Huang ZP, Pechivanis M, Kuhlmann J, Brunsveld L, Chandra A, Ellinger B, Waldmann H, Bastiaens PI (2010) The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell 141:458\u2013471","journal-title":"Cell"},{"key":"667_CR79","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M801902200","volume":"283","author":"Y Takeda","year":"2008","unstructured":"Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, Suzuki M, Minami S, Iwasaki T, Goya S, Kijima T, Kumagai T, Yoshida M, Osaki T, Komori T, Mekada E, Kawase I (2008) Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem 283:26089\u201326097","journal-title":"J Biol Chem"},{"key":"667_CR80","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1210\/jc.2014-3082","volume":"100","author":"A Reich","year":"2015","unstructured":"Reich A, Bae AS, Barnes AM, Cabral WA, Hinek A, Stimec J, Hill SC, Chitayat D, Marini JC (2015) Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. J Clin Endocrinol Metab 100:E325\u2013E332","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0667-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0667-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T14:53:24Z","timestamp":1652194404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-015-0667-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s00774-015-0667-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}